Effects of a polymerized ultrapurified bovine hemoglobin blood substitute administered to ponies with normovolemic anemia

Journal of Veterinary Internal Medicine

Volumn 16, Issue 4, 2002, Pages 396-403

  Belgrave, Rodney L ^a   Hines, Melissa T ^a   Keegan, Robert D ^a   Wardrop, K Jane ^a   Bayly, Warwick M ^a   Sellon, Debra C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Anaphylactoid reaction; Hetastarch; Horse; Oxygen transport; Transfusion

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; HETASTARCH; POLYMER;

ANEMIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD TRANSFUSION; CATTLE; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HEMODYNAMICS; HORSE; HORSE DISEASE; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANEMIA; ANIMALS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CATTLE; CENTRAL VENOUS PRESSURE; CROSS-OVER STUDIES; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HETASTARCH; HORSE DISEASES; HORSES; MALE; POLYMERS; TREATMENT OUTCOME;

EID: 0036636956     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb01256.x     Document Type: Article

References (30)

1. Teicher BA, Schwartz GN, Sotomayor EA, et al. Oxygenation of tumours by a hemoglobin solution. J Cancer Res Clin Oncol 1993; 120:85-90
2. Harringer W, Hodakowski GT, Svizzero T, et al. Acute effects of massive transfusion of a bovine hemoglobin blood substitute in a canine model of hemorrhagic shock. Eur J Cardiothorac Surg 1992;6: 649-654.
3. Manning JE, Katz LM, Brownstein MR, et al. Bovine hemoglobin based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Shock 2000;13:152-159
4. Maxson AD, Giger U, Sweeney CR, et al. Use of a bovine hemoglobin preparation in the treatment of cyclic ovarian hemorrhage in a miniature horse. J Am Vet Med Assoc 1993;203:1308-1311
5. Auer JA. Equine Surgery, 1st ed. Philadelphia, PA: WB Saunders; 1992:518-519.
6. Dailey RH. Use of wire-guided (Seldinger-type) catheters in the emergency department. Ann Emerg Med 1983;12:489-492.
7. Radin MJ, Eubank MC, Weiser MG. Electronic measurement of erythrocyte volume and volume heterogeneity in horses during erythrocyte regeneration associated with experimental anemias. Vet Pathol 1986;23:656-660.
8. Parry BW, Bayly WM, Tarr B. Indocyanine green clearance and estimation of plasma volume in the normal horse. Equine Vet J 1989; 21:142-144.
9. Clarke LL, Argenzio RA, Roberts MC. Effect of meal feeding on plasma volume and urinary electrolyte clearance in ponies Am J Vet Res 1990;51:571-576.
10. Muir WW, Skarda RT, Milne DW. Estimation of cardiac output in the horse by thermodilution techniques. Am J Vet Res 1976;37: 697-700.
11. Glantz SA, Slinker BK. Primer of Applied Regression and Analysis of Variance, 2nd ed. New York: McGraw-Hill; 2000:437-443, 468-482.
12. Koestner A. Neuropathology of canine epilepsy. Probl Vet Med 1989;1:516-534
13. Hayward R, Lefer AM. Administration of polymerized bovine hemoglobin improves survival in a rat model of traumatic shock. Methods Find Exp Pharmacol 1999;21:427-433.
14. Doss DN, Estefanous FG, Ferrario CM. Mechanism of systemic vasodilation during normovolemic hemodilution. Anesth Analg 1995; 81:30-34.
15. Spahn DR, Leone BJ, Reves JG. Cardiovascular and coronary physiology of acute isovolemic hemodilution: A review of non-oxygen carrying and oxygen-carrying solutions. Anesth Analg 1994;78:1000-1021.
16. Posner LP, Moon PF, Bliss SP, et al. Plasma colloid osmotic pressure after blood volume repletion with Oxyglobin.® hetastarch, or whole blood in pregnant sheep. Annual Meeting of the American College of Veterinary Anesthesiologists, 2000.
17. Bosman RJ, Minten J, Lu HR, et al Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Anesth Analg 1992;75:811-817.
18. Walton RS. Polymerized hemoglobin versus hydroxyethyl starch in an experimental model of feline hemorrhagic shock. 5th International Veterinary Emergency Critical Care Symposium, 1996.
19. Biopure Corporation. Oxyglobin® package insert. Cambridge, MA: Biopure Corporation; 2000.
20. Winslow RM. New transfusion strategies: Red cell substitutes. Annu Rev Med 1999;50:337-353.
21. Troubworst A, van Bommel J, Ince C. Monitoring normovolaemic haemodilution. Br J Anaesth 1998;81(Suppl 1):73-78.
22. Rooney MW, Hirsch LJ, Mathru M. Hemodilution with oxyhemoglobin. Anesthesiology 1993;79:60-72.
23. Fontana JL, Welborn L, Mongan PD, et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 1995;80:219-225.
24. Habler O, Mebmer K. Hyperoxaemia in extreme haemodilution. Br J Anaesth 1998;81(Suppl 1):79-82.
25. Ickx BE, Rigolet M, Van der Linden PJ. Cardiovascular and metabolic response to acute normovolemic anemia. Anesthesiology 2000;93:1011-1016.
26. Clerbeaux T, Gustin P, Detry B, et al. Comparative study of the oxyhaemoglobin dissociation curve of four mammals: Man. dog, horse, and cattle. Comp Biochem Physiol Comp Physiol 1993;106: 687-694.
27. Zimmel DN, Blikslager AT, Jones SL, et al. Vaccine associated anaphylactic-like reaction in a horse. Compend Cont Educ 2000;22: 81-85.
28. Jones PA, Tomasic M, Gentry PA. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies. Am J Vet Res 1997;58:541-548.
29. Stump DC, Strauss RG, Henriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985;25:349-354.
30. Smiley LE. The use of hetastarch for plasma expansion. Probl Vet Med 1992;4:652-667.